Publications by authors named "M Badoz"
Article Synopsis
- The peQasus study evaluates the safety and effectiveness of a new temperature-controlled high-power short-duration (HPSD) radiofrequency catheter (QDOT Micro) for pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF).
- Conducted across 15 centers in Europe, the study involved 1,023 patients and compared outcomes between a very HPSD technique and a hybrid approach.
- Results indicated complete PVI success, a mean procedure time of about 98 minutes, and a similar safety profile for both techniques, with 12-month arrhythmia-free survival rates around 77%.
Background And Aims: Prophylactic implantable cardioverter-defibrillators (ICDs) are not recommended until left ventricular ejection fraction (LVEF) has been reassessed 40 to 90 days after an acute myocardial infarction. In the current therapeutic era, the prognosis of sustained ventricular arrhythmias (VAs) occurring during this early post-infarction phase (i.e.
View Article and Find Full Text PDFBackground: The optimal strategy in prosthetic heart valve thrombosis (PVT) remains controversial, with no randomized trials and conflicting observational data. We performed a systematic review and meta-analysis of evidence comparing systemic thrombolysis and cardiac surgery in PVT.
Methods And Results: We searched PubMed, the Cochrane Library, and Embase for studies on treatment strategies in patients with left-sided PVT since 2000.
Objectives: Up to 20 % of ischemic strokes are associated with overt atrial fibrillation (AF). Furthermore, silent AF was detected by an implantable cardiac monitor (ICM) in 1 in 3 cryptogenic strokes in the CRYSTAL AF study. An ESC position paper has suggested a HAVOC score ≥ 4 or a Brown ESUS-AF score ≥ 2 as criteria for ICM implantation after cryptogenic stroke, but neither of these criteria has been developed or validated in ICM populations.
View Article and Find Full Text PDFArticle Synopsis
- The PFO-AF study aims to investigate the onset and recurrence of atrial fibrillation (AF) in patients who have undergone a procedure to close a patent foramen ovale (PFO) after suffering a stroke, utilizing implanted cardiac monitors for accurate data collection.
- It will involve 250 patients and track AF occurrences two months before and up to two years after the PFO closure, focusing on monitoring any AF episodes recorded by the cardiac device.
- The study is ethically approved and its results will be shared at conferences and in scientific journals to contribute to the understanding of AF in this patient population.